x

MIRA PHARMACEUTICALS, INC. (Nasdaq:MIRA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1904286
Company

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.

Address
855 North Wolfe Street
Suite 601.2
Baltimore, Maryland 21205
Employees
None
Stock Info
Close
$0.9300
Day Range
0.9106 - 1.0100
52 Week Range
0.7900 - 7.9799
Average volume
233.63K
Short Interest
107.27K (02/15/24)
% of Float Shorted
1.33%
Market Cap
$14.63M
Revenue
N/A
Net Income
-$7.06M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.5418
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Executive Chairman
Christopher C Chapman Jr., MD
Chief Executive Officer & Director
Erez Aminov
Director
Michael Jerman MBA
Independent Director
Talhia T Tuck
Independent Director
Hugh McColl III, MBA
Independent Director
Brad Kroenig
SEC filings
DateFormEvent
20 Dec, 2024 8-K
19 Dec, 2024 8-K
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 4
10 Dec, 2024 8-K
10 Dec, 2024 4
10 Dec, 2024 4
27 Nov, 2024 4
26 Nov, 2024 3
21 Nov, 2024 8-K
19 Nov, 2024 144
19 Nov, 2024 8-K
12 Nov, 2024 10-Q
25 Oct, 2024 8-K
21 Oct, 2024 8-K
27 Sep, 2024 424B5
27 Sep, 2024 S-8
12 Sep, 2024 8-K
10 Sep, 2024 8-K
6 Sep, 2024 144/A
4 Sep, 2024 144
30 Aug, 2024 4
23 Aug, 2024 8-K
16 Aug, 2024 10-Q/A
16 Aug, 2024 EFFECT
15 Aug, 2024 CORRESP
15 Aug, 2024 UPLOAD
13 Aug, 2024 10-Q
12 Aug, 2024 S-3
9 Aug, 2024 8-K
8 Aug, 2024 8-K
26 Jul, 2024 DEF 14A
26 Jul, 2024 DEFA14A
24 Jul, 2024 8-K
19 Jul, 2024 8-K
12 Jul, 2024 8-K
28 Jun, 2024 8-K
21 Jun, 2024 4
30 May, 2024 4
29 May, 2024 8-K
22 May, 2024 4
13 May, 2024 10-Q
1 Apr, 2024 10-K
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
27 Mar, 2024 4
22 Mar, 2024 3
22 Mar, 2024 3
22 Mar, 2024 3
13 Mar, 2024 8-K
7 Mar, 2024 8-K
17 Jan, 2024 8-K
27 Dec, 2023 SC 13D/A
27 Dec, 2023 4
27 Dec, 2023 EFFECT
22 Dec, 2023 CORRESP
22 Dec, 2023 UPLOAD
18 Dec, 2023 S-1
1 Dec, 2023 8-K
20 Nov, 2023 8-K
20 Nov, 2023 3
20 Nov, 2023 SC 13D/A
17 Nov, 2023 4
14 Nov, 2023 424B3
13 Nov, 2023 10-Q
3 Nov, 2023 3
25 Oct, 2023 8-K
12 Oct, 2023 3
12 Oct, 2023 SC 13D/A
18 Sep, 2023 424B3
15 Sep, 2023 10-Q
31 Aug, 2023 8-K
24 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
21 Aug, 2023 4
14 Aug, 2023 SC 13D
7 Aug, 2023 8-K
4 Aug, 2023 4
4 Aug, 2023 424B4
4 Aug, 2023 424B1 IPO completed
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 3
2 Aug, 2023 EFFECT
2 Aug, 2023 3
31 Jul, 2023 CORRESP
31 Jul, 2023 CORRESP
31 Jul, 2023 CERT
31 Jul, 2023 8-A12B
28 Jul, 2023 S-1/A
25 Jul, 2023 S-1/A
21 Jul, 2023 S-1/A
18 Jul, 2023 S-1/A
14 Jul, 2023 CORRESP
13 Jul, 2023 CORRESP
10 Jul, 2023 UPLOAD
29 Jun, 2023 S-1
29 Jun, 2023 CORRESP
15 Jun, 2023 UPLOAD
8 Jun, 2023 DRSLTR
8 Jun, 2023 DRS/A
30 May, 2023 UPLOAD
2 May, 2023 DRS/A
1 Aug, 2022 D
1 Aug, 2022 D
29 Jun, 2022 DRS
Last update:2024-03-06 12:21:30.680221
MIRA PHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe